Valuable Lessons for Pharmaceutical Manufacturing During a Pandemic
Summary: The pandemic has made us question how the future of pharma manufacturing will be altered post Covid-19. Broader and deeper collaboration, new ways of working, and proactive investment will intersect with revolutionary manufacturing and distribution approaches, an unprecedented pace of innovation, AI, and precision medicines becoming commonplace. Hear from the CEO of a leading pharmaceutical manufacturer that works on hundreds of molecules and thousands of products across multiple modalities and routes of administration.